The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Diacrin, Inc.

Diacrin, Inc.
Nasdaq: DCRN
Change
symbol:
     
 PROFILE
Diacrin goes hog wild treating diseases. The development-stage company concentrates on cell therapy, using pig cells to develop therapies for people; it is also developing technologies to prevent human bodies from rejecting transplanted pig cells. In 1995 the firm conducted the first clinical trials of such xenotransplants. Through a joint venture with Genzyme, Diacrin is developing treatments for Parkinson's and Huntington's diseases. The company is also working on treatments for epilepsy, stroke, spinal cord injuries, liver disease, and cardiac disease. Healthcare-focused venture capital firm HealthCare Ventures owns 25% of Diacrin.

 COMPETITION
Guilford Pharmaceuticals Inc. (GLFD)
NeoTherapeutics, Inc. (NEOT)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 5.20
1-Yr. Sales Growth: 73.3%
Employees: 38
Revenue per employee: $136,842.11

 KEY PEOPLE
• Thomas H. Fraser
    CEO

 CONTACT INFO
Charlestown Navy Yard, Bldg. 96, 13th St.
Charlestown, MA 02129
US
Phone: 617-242-9100
Fax: 617-242-0070
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001